---
title: AXOlabs vs CatSci
slug_a: axolabs
slug_b: catsci
site: cro
review_signal_gate: closed
canonical_path: /compare/axolabs/catsci
---

# AXOlabs vs CatSci

Side-by-side profile data from each company listing on this directory.

## AXOlabs

- Profile: [/companies/axolabs](/companies/axolabs)

AXOlabs — Integrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany.

Services: 13. Modalities: 1. Indications: 0. Locations: 3. Certifications: 2. The strongest documented coverage currently appears in services (13).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- In Vitro Pharmacology
- In Vivo PK / PD Studies
- GLP Toxicology
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Bioinformatics & Data Science
- Oligonucleotide Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development

### Modalities

- Oligonucleotide

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)
- Phase I
- Phase II
- Phase III

### Sourcing models

- Full-Service Outsourcing (FSO)

## CatSci

- Profile: [/companies/catsci](/companies/catsci)

CatSci — UK-based partner for small molecule and complex synthetic medicines, offering route selection, process development, GMP drug substance manufacture and analytical services across four European and UK sites.

Services: 10. Modalities: 3. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (10).

### Services

- Medicinal Chemistry
- Analytical Method Development & Validation
- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Solid-State Chemistry & Polymorph Screening
- Oligonucleotide Manufacturing
- Peptide Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development

### Modalities

- Small Molecule
- Oligonucleotide
- Peptide

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (IND-Enabling)
- Phase I
- Phase II
- Phase III

### Sourcing models

- Data not yet provided.